BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has appointed a new scientific advisory board member: Dr. Matthias Dobbelstein, director of the Institute of Molecular Oncology at the University Medical Center Göttingen in Germany since 2005 and also…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in the Virtual Investor “Ask the CEO” event. The live, moderated event is intended to provide the investment…
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is leading RNG development by acquiring, developing, building, and operating a portfolio of RNG, waste-to-energy and related infrastructure projects. “The company aims to expand its network across the country with support from Canada’s energy sector – an…
Cepton (NASDAQ: CPTN) is a Silicon Valley innovator of lidar-based solutions for autonomous vehicle (“AV”) and advanced driver assistance system (“ADAS”) sectors. “Cepton leads the way in enabling the world’s leading automotive companies to integrate lidar at scale and transition to an increasingly adaptive, safety-centric future. Safety is at the forefront of ADAS/AV technology concerns,…
HeartBeam (NASDAQ: BEAT) was recently named the winner of the annual Cardiovascular Innovations (“CVI”) 2022 Information Summit and Shark Tank Competition, an annual conference that focuses on innovative health solutions for cardiology clinicians. Awards presented at the conference recognize state-of-the-art cardiac technologies. “The company, which has developed the first and only 3D-vector ECG platform for…
Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has been acquired by MICT Inc. (NASDAQ: MICT); the transaction was completed today. According to the announcement, the agreement includes 100% ownership of Tingo Inc.’s operating business and assets, specifically its subsidiary, Tingo Mobile Limited; 100% consolidation of Tingo Mobile’s revenues and income; 100% consolidation of Tingo…
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that it continues to accelerate market expansion with five new contracts for its Autonomous Security Robot (“ASR”) services in the health care market across multiple U.S. states. Describing deployment locations across a hospital group in Minnesota, an…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced the pricing of a public offering. The offering is comprised of 1,889,764 shares of common stock (or prefunded warrants in lieu thereof) along with warrants to purchase up…
Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“NAFTA”) region, is expanding its training program. The company announced that it is working with a leading…
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company that focuses on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is reporting on its third quarter, the period ending Sept. 30, 2022; the report also included key company updates. Highlights of the report included the strategic research collaboration between…
Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider, today announced a solar energy installation project totaling 3.8 megawatts with EnerSys(R) (NYSE: ENS), the global leader in stored energy solutions, at its global headquarters in Pennsylvania. According to the announcement, this will officially be one of the largest behind-the-meter solar…
Vision Energy (OTCQB: VIHDD) today announced that it has engaged Rho Adviseurs, a Netherlands-based firm specializing in spatial planning and permit management, for the company’s pioneering Green Energy Hub development project in the North Sea Port of Vlissingen, the Netherlands. The project is being designed to provide import, storage and handling facilities for hydrogen carriers,…
MICT (NASDAQ: MICT) previously announced that it is scheduled to complete the acquisition of the operating business and assets of Tingo (OTC: TMNA) by Nov. 30, 2022. This will be achieved through the acquisition of 100% of Tingo’s sole operating subsidiary, Tingo Mobile Limited. In return, MICT is issuing 19.9% of its common stock to…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced its projected revenue growth for the next 12 months. The company has seen accelerated year-over-year growth, and with the increased interest as well as impressive upswing in signed contracts, Knightscope anticipates tripling annualized revenue. In addition, the company released the first in…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its patented DehydraTECH-CBD(TM) has demonstrated performance enhancements compared to one of the world’s leading anti-seizure medications, Epidiolex(R). According to the update, animal study program EPIL-A21-1 was designed to determine whether DehydraTECH-CBD could provide similar seizure inhibiting efficacy, using an established,…
BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company today announced statistically significant (p<0.001) efficacy results in a preclinical in vivo proof-of-concept study of its innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy. “We are excited that the…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced assay results from eight additional diamond drill holes from its ongoing drilling program at the Iska Iska silver-tin polymetallic project in the Potosi Department, southern Bolivia. According to the update, six of the holes (DSB-35 and DSB-37 to DSB-41) tested the south-southeastern extension of the…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced a 1-for-30 reverse split of its common stock. According to the announcement, the split was effective at 4:01 p.m. ET on Nov. 28, 2022. Starting today, CNSP common stock…